Research Articles
Breaking the Shield: How New Drugs Target Aggressive Lymphoma at Its Genetic Core
The revolutionary science behind ETS inhibitors and their powerful synergy with immunotherapy in fighting treatment-resistant blood cancers
The Secret Betrayal: How Your Microenvironment Turns Drugs Against You in Lymphoma
Discover how the tumor microenvironment actively secretes molecules that shield cancer cells from PI3Kδ inhibitors in marginal zone lymphoma, and the breakthrough combination therapies overcoming this resistance.